QUICNAC AB

Quicnac AB Tablet is indicated for the management and prevention of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), including bronchitis and complications associated with pulmonary cystic fibrosis. This medication functions by relaxing the muscles around the airways, facilitating easier breathing for individuals suffering from these conditions. The administration of Quicnac AB can be done with or without food, and it is essential that the dosage and duration of the treatment are strictly adhered to as prescribed by your healthcare provider. The specific dosage prescribed will be tailored to your individual health status and response to the treatment. Continuously using this medication as directed is critical; discontinuing it prematurely could lead to a resurgence of symptoms and a possible deterioration of your health condition. It is important to communicate with your healthcare provider about any other medications you are currently using, as there may be potential interactions that could influence the effectiveness or safety of Quicnac AB. Some common adverse reactions include nausea, vomiting, headaches, and dizziness, which are typically temporary and may resolve naturally over time. If you experience any concerning side effects, it is advisable to reach out to your doctor promptly. It is paramount to refrain from self-medication or sharing this medication with others. Prior to starting treatment, make sure to inform your healthcare provider if you have any existing kidney or liver conditions, are pregnant, planning to become pregnant, or are breastfeeding.